Decrease of Atazanavir and Lopinavir Plasma Concentrations in a Boosted Double Human Immunodeficiency Virus Protease Inhibitor Salvage Regimen

The human immunodeficiency virus protease inhibitor combination of atazanavir (ATV)-lopinavir-ritonavir was reported to exhibit a mutual pharmacoenhancement of plasma lopinavir and ATV concentrations which may be beneficial for salvage patients. We identified 17 patients in our pharmacokinetic datab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: von Hentig, Nils, Kaykhin, Pavel, Stephan, Christoph, Babacan, Errol, Stürmer, Martin, Staszewski, Schlomo, Lötsch, Jörn
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2008
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2415773/
https://ncbi.nlm.nih.gov/pubmed/18411323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01565-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados